一个虚拟实践社区,以赋予最近患有缺血性心脏病的患者权力:一个随机对照试验
Helena Vall-Roqué1, Vanesa Ramos-García2, Amado Rivero-Santana2
1Avedis Donabedian Research Institute (FAD).
概括
虚拟实践社区 (vCoPs) 在缺血性心脏病 (IHD) 患者中改善了地中海饮食的坚持. 然而,vCoPs并没有显著改善患者的激活或生活质量,并注意到高退学率.
科学领域:
- 心脏病学和数字健康
背景情况:
- 缺血性心脏病 (IHD) 的管理需要患者的参与和生活方式的修改.
- 虚拟实践社区 (vCoPs) 为患者提供支持和教育提供了一个数字平台.
研究的目的:
- 评估基于Web 2.0的vCoP在增强IHD患者患者激活方面的有效性.
- 评估vCoP干预对二次结果的影响,包括饮食,体力活动和生活质量.
主要方法:
- 一项随机对照试验,涉及西班牙282名IHD患者.
- 干预组接受了多组件定制的vCoP,重点是患者赋权技能.
- 主要结局:患者激活度量得分;次要结局:自我效能,饮食,体力活动,心理健康,药物服药,生活质量.
主要成果:
- 在6,12和18个月的vCoP组中观察到地中海饮食的坚持显著改善 (B = 0.86,95% CI [0.36,1.35]).
- 在患者激活,自我效能,体力活动,抑郁,焦虑,药物坚持或与健康相关的生活质量方面没有发现统计学意义上的变化.
结论:
- 虚拟实践社区显示出改善IHD患者遵守地中海饮食的潜力.
- 该研究没有显示出患者激活或生活质量的显著改善,这可能是由于参与者中断率高.
- 需要进一步的研究来阐明慢性疾病管理中的vCoP干预措施中的行为改变机制.
相关概念视频
Ischemic Heart Disease: Overview
1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Patient-centered Care
1.9K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
1.9K
Coronary Circulation
2.2K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
2.2K
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
147
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
147


